What is Birt-Hogg-Dube syndrome? Symptoms and treatment

What is Birt-Hogg-Dubé syndrome?
Birt-Hogg-Dubé syndrome (BHD) is associated with an increased risk of multiple noncancerous (benign) skin tumors, lung cysts and kidney lesions (cysts, benign tumors and kidney cancer), and is an inherited condition. Signs of this syndrome usually do not appear until adulthood.
The most common skin tumors in Birt-Hogg-Dubé syndrome (BHD) are fibrofolliculomas. Fibrofolliculomas are pale or skin-colored tumors that form in hair follicles. Other skin tumors associated with BHD are trichodiscomas. Researchers are investigating whether fibrofolliculomas and trichodiscomas are different stages of a single process rather than different tumors.
Skin lesions that may occur in Birt-Hogg-Dubé syndrome can be seen below:

Lung cysts in BHD are generally at the base of the lungs and are not associated with smoking. These cysts generally do not cause breathing problems, and there are currently no data showing that they increase lung cancer risk. However, cysts can rupture, increasing the risk of air leaking from the lungs into the chest cavity. Many different types of kidney tumor have been seen in people with BHD. The most common are hybrid oncocytic tumors (HOTs), chromophobe tumors and oncocytomas. In BHD, tumors commonly occur in both kidneys and at multiple sites. Although they appear to grow slowly when monitored, they are likely to spread if untreated.

What causes BHD?
BHD is a genetic condition. This means that BHD-related cancer risk and other features of BHD can be passed from generation to generation within a family. Nearly all cases are caused by a mutation in a specific gene called FLCN, which makes a protein called folliculin. FLCN is currently thought to be a tumor-suppressor gene. The main role of a tumor-suppressor gene is to make proteins that prevent tumor formation by limiting cell growth. Clinical research to learn more about BHD is ongoing.
How is BHD passed to later generations?
Normally, each cell has 2 copies of a gene, one inherited from the mother and one from the father. BHD follows an autosomal dominant inheritance pattern, meaning that a mutation in just one copy is sufficient for it to occur. A parent with a gene mutation can therefore pass either a normal copy or a mutated copy to their child. A child of a parent with the mutation thus has a 50% chance of inheriting it. A brother, sister or parent of a person with the mutation also has a 50% chance of carrying the same mutation. In some cases, a genetic mutation may be found even when a mutated gene has not been passed down by either parent. These are called novo cases.
A mutation in only one gene copy is enough to cause BHD. However, current research indicates that an acquired second mutation (a somatic mutation) in the normal FLCN allele, a particular version of a gene, is needed for tumors to form. When both copies of FLCN are altered, the cell loses its ability to suppress tumor growth and prevent tumor formation.
Some options are available for people with a hereditary cancer syndrome who wish to have children. Preimplantation genetic diagnosis (PGT), a medical procedure performed with in vitro fertilization (IVF), can allow them to have children without passing on a specific gene mutation. The woman’s eggs are removed and fertilized in a laboratory. When embryos reach a certain size, approximately 8 cells, 1 cell is removed and tested for the hereditary condition in question. Parents may then choose to transfer embryos without the mutation into the woman’s uterus. PGT has been used for more than twenty years to prevent various hereditary cancer-predisposition syndromes. However, it is a complex procedure involving financial, physical and emotional factors that should be considered before starting PGT.
How common is BHD?
BHD is thought to be rare. Although the exact number of people and families with BHD is unknown, the estimated average carrier frequency is 1 in every 200,000 people.
How is BHD diagnosed?
BHD is suspected when a person has BHD-associated skin tumors (fibrofolliculomas) along with a personal or family history of lung cysts, air leaking from the lungs or kidney cancer. BHD should be considered if more than one person in the family has kidney cancer, if there is more than one type of kidney cancer in the family, or if a person has particular types of kidney cancer known to be associated with BHD. Genetic tests that detect mutations in FLCN are available for people wishing to be screened for BHD.
What are the estimated cancer risks associated with BHD?
People with BHD have increased risks of kidney cancer, hybrid oncocytic tumors, chromophobe renal cell carcinoma (RCC) or oncocytoma. Clear-cell, papillary and unclassified tumors can also occur and are generally more aggressive when associated with BHD. The estimated kidney cancer risk in people with BHD is 15% to 30%.
What are the screening options for BHD?
There are no specific screening guidelines for BHD. Because of kidney cancer risk, some doctors recommend that people with BHD or a family history of BHD be screened periodically after age 20 using imaging such as ultrasound, tomography or MRI. However, ultrasound produces echoes similar to those of normal tissue and can sometimes miss these tumors, so most experts recommend periodic screening every two years with either computed tomography (CT) or magnetic resonance imaging (MRI). An examination by a dermatologist to evaluate the skin and a pulmonologist to assess any lung cysts is also recommended at the beginning of screening.
Screening guidelines may change over time as new technologies are developed and more is learned about BHD. You can discuss appropriate screening tests with your healthcare team.
Questions to ask your healthcare team
If you are concerned about your kidney cancer risk, talk with your healthcare team. It may help to bring someone to appointments to take notes. You can ask your healthcare team the following questions:
- What is my risk of developing kidney cancer?
- What can I do to reduce my cancer risk?
- What are my options for cancer screening?
If you are concerned about your family history and think your family may have BHD, you can ask the following questions:
- If I had a collapsed lung (due to air leaking out of the lung), could this be related to a genetic condition?
- Does my family history increase my risk of developing kidney cancer?
- Are skin tumors in me or my family members associated with BHD?
- Do you think I should have a cancer risk assessment? If so, would you refer me to a genetic counselor or another genetics specialist?
- Should I consider genetic testing?
Sources
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.